<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00155129</url>
  </required_header>
  <id_info>
    <org_study_id>9361701099</org_study_id>
    <secondary_id>9361701099</secondary_id>
    <nct_id>NCT00155129</nct_id>
  </id_info>
  <brief_title>The Role of CGRPand Nociceptin in Migraine</brief_title>
  <official_title>The Role of Calcitonin Gene-Related Peptide(CGRP)and Nociceptin in the Pathogenesis of Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      The release of the neuropeptide calcitonin gene-related peptide (CGRP) is thought to play a
      causative role in migraine. Nociceptin immunoreactivity and ORL-1 mRNA have been detected in
      human trigeminal ganglia where it was co-localized with CGRP. It may play a role in migraine
      pathogenesis. We are collecting the blood samples of migraineurs for analysis of these
      neuropeptides.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The release of the neuropeptide calcitonin gene-related peptide (CGRP) is thought to play a
      causative role in migraine. Nociceptin immunoreactivity and ORL-1 mRNA have been detected in
      human trigeminal ganglia where it was co-localized with CGRP. It may play a role in migraine
      pathogenesis. We are collecting the blood samples of migraineurs for analysis of these
      neuropeptides.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date>June 2005</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Cross-Sectional, Prospective</time_perspective>
  </study_design_info>
  <enrollment>200</enrollment>
  <condition>Migraine</condition>
  <condition>Headache</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: patients with headache -

        Exclusion Criteria: fever, congenital anomaly, CNS organic lesions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pi-Chuan Fan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatric, NTUH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pi-Chuan Fan, MD</last_name>
    <email>pcfan@ntumc.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li-Chu Chiou, PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Pediatrics</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pi-Chuan Fan, MD</last_name>
      <phone>886-2-23123456</phone>
      <phone_ext>5135</phone_ext>
      <email>pcfan@ntumc.org</email>
    </contact>
    <investigator>
      <last_name>Pi-Chuan Fan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>September 9, 2005</last_update_submitted>
  <last_update_submitted_qc>September 9, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 12, 2005</last_update_posted>
  <keyword>migraine</keyword>
  <keyword>CGRP</keyword>
  <keyword>nociceptin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nociceptin</mesh_term>
    <mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
    <mesh_term>Nocistatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

